The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Artificial intelligence in gynecologic cancers: Current status and future challenges – A systematic review
Abstract
OBJECTIVE Over the past years, the application of artificial intelligence (AI) in medicine has increased rapidly, especially in diagnostics, and in the near future, the role of AI in medicine will become progressively more important. In this study, we elucidated the state of AI research on gynecologic cancers. METHODS A search was conducted in three databases-PubMed, Web of Science, and Scopus-for research papers dated between January 2010 and December 2020. As keywords, we used "artificial intelligence," "deep learning," "machine learning," and "neural network," combined with "cervical cancer," "endometrial cancer," "uterine cancer," and "ovarian cancer." We excluded genomic and molecular research, as well as automated pap-smear diagnoses and digital colposcopy. RESULTS Of 1632 articles, 71 were eligible, including 34 on cervical cancer, 13 on endometrial cancer, three on uterine sarcoma, and 21 on ovarian cancer. A total of 35 studies (49%) used imaging data and 36 studies (51%) used value-based data as the input data. Magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, cytology, and hysteroscopy data were used as imaging data, and the patients' backgrounds, blood examinations, tumor markers, and indices in pathological examination were used as value-based data. The targets of prediction were definitive diagnosis and prognostic outcome, including overall survival and lymph node metastasis. The size of the dataset was relatively small because 64 studies (90%) included less than 1000 cases, and the median size was 214 cases. The models were evaluated by accuracy scores, area under the receiver operating curve (AUC), and sensitivity/specificity. Owing to the heterogeneity, a quantitative synthesis was not appropriate in this review. CONCLUSIONS In gynecologic oncology, more studies have been conducted on cervical cancer than on ovarian and endometrial cancers. Prognoses were mainly used in the study of cervical cancer, whereas diagnoses were primarily used for studying ovarian cancer. The proficiency of the study design for endometrial cancer and uterine sarcoma was unclear because of the small number of studies conducted. The small size of the dataset and the lack of a dataset for external validation were indicated as the challenges of the studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Wolff, R. F., Moons, K. G. M., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., Mallett, S., & for the PROBAST Group† (2019) · Annals of Internal Medicine · doi:10.7326/m18-1376 · Cited by 2,984
Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study
Chilamkurthy, S., Ghosh, R., Tanamala, S., Biviji, M., Campeau, N. G., Venugopal, V. K., Mahajan, V., Rao, P., & Warier, P. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31645-3 · Cited by 1,020
Application of machine learning to predict the recurrence-proneness for cervical cancer
Tseng, C.-J., Lu, C.-J., Chang, C.-C., & Chen, G.-D. (2014) · Neural Computing and Applications · doi:10.1007/s00521-013-1359-1 · Cited by 128
Tseng, C.-J., Lu, C.-J., Chang, C.-C., Chen, G.-D., & Cheewakriangkrai, C. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.06.003 · Cited by 76
Martínez-Más, J., Bueno-Crespo, A., Khazendar, S., Remezal-Solano, M., Martínez-Cendán, J.-P., Jassim, S., Du, H., Al Assam, H., Bourne, T., & Timmerman, D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219388 · Cited by 70
Aramendía-Vidaurreta, V., Cabeza, R., Villanueva, A., Navallas, J., & Alcázar, J. L. (2016) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.11.014 · Cited by 47
Cited by
Celard, P., Iglesias, E. L., Sorribes-Fdez, J. M., Romero, R., Vieira, A. S., & Borrajo, L. (2023) · Neural Computing and Applications · doi:10.1007/s00521-022-07953-4 · Cited by 188
Cai, Y., Cai, Y.-Q., Tang, L.-Y., Wang, Y.-H., Gong, M., Jing, T.-C., Li, H.-J., Li-Ling, J., Hu, W., Yin, Z., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03273-7 · Cited by 122
Hsu, S.-T., Su, Y.-J., Hung, C.-H., Chen, M.-J., Lu, C.-H., & Kuo, C.-E. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-02047-6 · Cited by 58
Metadata
- Authors
- Akazawa, M., & Hashimoto, K.
- Venue
- Artificial Intelligence in Medicine
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 120
- Pages
- 102164
- ISSN
- 0933-3657 (ISSN-L)
- OpenAlex
- W3197006915
- Cited by
- 160
- References
- 8
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial intelligence in gynecologic cancers: Current status and future challenges – A systematic review. https://app.cochat.ai/papers/10.1016/j.artmed.2021.102164
- The paper
- Akazawa, M., & Hashimoto, K. (2021). Artificial intelligence in gynecologic cancers: Current status and future challenges – A systematic review. Artificial Intelligence in Medicine. https://doi.org/10.1016/j.artmed.2021.102164
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.